Japanese pediatric patient with moderately active ulcerative colitis successfully treated with ustekinumab: A case report.

To the best of our knowledge, this is the first pediatric case of moderately active UC successfully treated with ustekinumab in Japan. Ustekinumab combined with steroids is an effective and safe induction therapy for UC.